Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue

Cancer Letters

Volumn 154, Issue 2, 2000, Pages 143-149

  Santella, Regina M ^e   Gammon, Marilie D ^a   Zhang, Yu Jing ^e   Motykiewicz, Grazyna ^e   Young, Tie Lan ^e   Hayes, Sharon C ^e   Terry, Mary Beth ^a   Schoenberg, Janet B ^b   Brinton, Louise A ^c   Bose, Shikha ^d   Teitelbaum, Susan L ^a   Hibshoosh, Hanina ^d  

^a Joseph L Mailman Sch Pub Hlth C ^*  (United States)

^b NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE

Author keywords

Breast cancer; Cigarette smoking; Immunohistochemistry; Polycyclic aromatic hydrocarbon DNA adducts

Indexed keywords

POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P53;

ARTICLE; BREAST CANCER; CIGARETTE SMOKING; DNA ADDUCT; DNA DAMAGE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; POLYCYCLIC HYDROCARBONS, AROMATIC; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034733865     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00367-0     Document Type: Article

References (42)

1. SEER, National Cancer Institute's Surveillance, Epidemiology, and End Results, Breast Cancer, January, 1997.
2. Kelsey J.L., Bernstein L. Epidemiology and prevention of breast cancer. Ann. Rev. Publ. Health. 17:1996;47-67.
3. Brinton L.A., Benichou J., Gammon M.D., Brogan D.R., Coates R., Schoenberg J.B. Ethnicity and variation in breast cancer incidence. Int. J. Cancer. 73:1997;349-355.
4. Madigan P.M., Ziegler R.G., Benichou J., Byrne C., Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl. Cancer Inst. 87:1995;1681-1685.
5. Ellisen L.W., Haber D.A. Hereditary breast cancer. Annu. Rev. Med. 49:1998;425-436.
6. El-Bayoumy K. Environmental carcinogens that may be involved in human breast cancer etiology. Crit. Rev. Toxicol. 5:1992;585-590.
7. Phillips D.H. Fifty years of benzo[a]pyrene. Nature. 303:1983;468-472.
8. Yuspa S.H., Poirier M.C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res. 50:1988;25-70.
9. Obana H., Hon S., Kashimoto T., Kunita N. Polycyclic aromatic hydrocarbons in human fat and liver. Bull. Environ. Contam. Toxicol. 27:1981;23-27.
10. Seidman L.A., Moore C.J., Gould M.N. 32P-postlabeling analysis of DNA adducts in human and rat mammary epithelial cells. Carcinogenesis. 9:1988;1071-1077.
11. Santella R.M. Immunologic methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol. Biomarkers Prev. 8:1999;733-739.
12. Schut H.A.J., Shiverick K.T. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. FASEB J. 6:1992;2942.
13. Li D., Wang M., Dhingra K., Hiffelman W.N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56:1996;287-293.
14. Perera F.P., Estabrook A., Hewer A., Channing K., Rundle A., Mooney L.A., Whyatt R., Phillips D.H. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev. 4:1995;233-238.
15. Palmer J.R., Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol. Rev. 15:1993;145-156.
16. Baron J.A., La Vecchia C., Levi F. The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet. Gyn. 162:1990;502-514.
17. Davis D.L., Pongsiri M.J., Wolff M. Recent developments on the avoidable causes of breast cancer. Ann. N. Y. Acad. Sci. 837:1997;513-523.
18. Poirier M.C. Development of Immunoassays for the Detection of Carcinogen-DNA Adducts. Groopman J.D., Skipper P.L. Molecular Dosimetry and Human Cancer: Analytical Epidemological and Social Considerations. 1991;211-230 CRC Press, Boca Raton, FL.
19. Mumford J.L., Williams K., Wilcosky T.C., Everson R.B., Young T.L., Santella R.M. A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat. Res. 359:1996;171-177.
20. Brinton L.A., Daling J.R., Liff J., Schoenberg J.B., Malone K.E., Stanford J.L., Coates R.J., Gammon M.D., Hanson L., Hoover R.N. Oral contraceptives and breast cancer risk among younger women. J. Natl. Cancer Inst. 87:1995;827-835.
21. Gammon M.D., Hibshoosh H., Terry M.B., Bose S., Schoenberg J.B., Brinton L.A., Bernstein J.L., Thompson W.D. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol. Biomarkers Prev. 8:1998;255-263.
22. Gammon M.D., Schoenberg J.B., Teitelbaum S.L., Brinton L.A., Potischman N., Swanson C.A., Brogan D.J., Coates R.J., Malone K.E., Stanford J.L. Cigarette smoking and breast cancer risk among young women. Cancer Causes Control. 9:1998;583-590.
23. Hsu T.M., Zhang Y.J., Santella R.M. Immunoperoxidase quantitation of 4-aminobiphenyl-and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 6:1997;193-199.
24. Daniel W.W. Biostatistics: A Foundation for Analysis in Health Sciences. 1991;Wiley, New York.
25. Li D., Zhang W., Wang M., Zhu Y., Hittleman W.N., Sahin A. Cellular distribution of aromatic DNA adducts in normal breast tissue of women with breast cancer. AACR Proc. 39:1998;491.
26. Zhang Y.J., Hsu T.M., Santella R.M. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 4:1995;133-138.
27. Binkova B., Hublek F., Sram R.J. Stability of benzo[a]pyrene DNA adducts in rat tissues during their long-term storage at -20°C or -80°C. Mutat. Res. 371:1996;229-235.
28. Huang Z., Fasco M.J., Figge H.L., Keyomarsi K., Kaminsky L.S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos. 24:1996;899-905.
29. Wang L.Y., Chen C.J., Zhang Y.J., Tsai W.Y., Lee P.H., Feitelson M.A., Lee C.S., Santella R.M. 4-Aminobiphenyl-DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am. J. Epidemiol. 147:1998;315-323.
30. Tang D.L., Santella R.M., Blackwood M.A., Young T.L., Mayer J., Tsai W.Y., Perera F.P. molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarkers Prev. 4:1995;341-346.
31. Szyfter K., Hemminki K., Szyfier W., Szmeja Z., Banaszewski J., Yang K. Aromatic DNA adducts in lamyx biopsies and leukocytes. Carcinogenesis. 15:1994;2195-2199.
32. Leszkowicz A.P., Grosse Y., Carriere V., Cugnenc P.H., Berger A., Camot F., Beaune P., de Waziers I. High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res. 55:1995;5611-5616.
33. van Schooten F.J., Hillebrand M.J.X., van Leeuwen F.E., van Zandwijk N., Jansen H.M., Den Engelse L., Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis. 13:1992;987-993.
34. Bennicke K., Carsten C., Sabroe S., Serensen H.T. Cigarette smoking and breast cancer. Br. Med. J. 310:1995;1431-1433.
35. MacMahon B., Trichopoulos D., Cole P., Brown J. Cigarette smoking and urinary estrogens. N. Engl. J. Med. 307:1982;1062-1065.
36. Westoff C., Gentile G., Lee J., Zacur H., Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am. J. Epidemiol. 144:1996;381-388.
37. van der Kooy K., Rookus M.A., Peterse H.L., van Lecuwen F.E. p53 protein overexpression in relation to risk factors for breast cancer. Am. J. Epidemiol. 144:1996;924-933.
38. Harris R.E., Zang E.A., Anderson J.I., Wynder E.L. Race and sex differences in lung cancer risk associated with cigarette smoking. Int. J. Epidemiol. 22:1993;592-599.
39. Biggs P.J., Warren W., Venitt S., Astratton M.R. The value of mutational spectra in unravelling the etiology of cancer. Mutagenesis. 8:1993;275-283.
40. Lurm R.M., Zhang Y.J., Wang L.Y., Chen C.J., Lee P.H., Lee C.S., Tsai W.Y., Santella R.M. p53 Mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57:1997;3471-3477.
41. Curigliano G., Zhang Y.J., Wang L.Y., Flamini G., Alcini A., Ratto C., Giustacehini M., Alcini B., Cittadini A., Santella R.M. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in Ti bladder cancer of smokers and nonsmokers. Carcinogenesis. 17:1996;101-106.
42. Martone T., Airoldi L., Magagnotti C., Coda R., Randone D., Malaveille C., Avanzi G., Merletti F., Hautefeuille A., Vineis P. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int. J. Cancer. 75:1998;512-516.